Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood

Journal of Autoimmunity

Volumn 21, Issue 3, 2003, Pages 277-281

  De Wit, Dominique ^a   Tonon, Sandrine ^a   Olislagers, Véronique ^a   Goriely, Stanislas ^a   Boutriaux, Michaël ^a   Goldman, Michel ^a   Willems, Fabienne ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Dendritic cell; Interferon ; Interleukin 12; LPS; Poly (I:C)

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 12; LIGAND; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN P70; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; BLOOD ANALYSIS; BLOOD CELL; BONE MARROW CELL; CIRCULATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NEWBORN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TH1 CELL; UMBILICAL CORD BLOOD; UPREGULATION;

EID: 0242655092     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2003.08.003     Document Type: Conference Paper

References (26)

1. Siegrist C.A. Vaccination in the neonatal period and early infancy. Int Rev Immunol. 19:2000;195-219.
2. White G.P., Watt P.M., Holt B.J., Holt P.G. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression betweenhuman neonatal and adult CD45RO-T cells. J Immunol. 168:(6):2002;2820-2827.
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol. 18:2000;767-811.
4. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2:(10):2001;947-950.
5. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol. 15:(1):2003;5-11.
6. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 194:(6):2001;863-869.
7. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:(6857):2001;732-738.
8. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol. 270:2002;109-120.
9. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4differentially activate human dendritic cells. J Biol Chem. 276:(40):2001;37692-37699.
10. Manetti R., Annunziato F., Tomasevic L., Gianno V., Parronchi P., Romagnani S., et al. Polyinosinic acid: polycytidylic acid promotes T helper,type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol. 25:(9):1995;2656-2660.
11. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J., Brand A., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol. 163:(1):1999;57-61.
12. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 189:(5):1999;821-829.
13. Tonon S., Goriely S., Aksoy E., Pradier O., Del Giudice G., Trannoy E., et al. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol. 32:(11):2002;3118-3125.
14. +dendritic cells to produce type I IFN. J Immunol. 166:(4):2001;2291-2295.
15. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 3:(2):2003;133-146.
16. Upham J.W., Lee P.T., Holt B.J., Heaton T., Prescott S.L., Sharp M.J., et al. Development of interleukin-12-producing capacity throughout childhood. Infect Immun. 70:(12):2002;6583-6588.
17. Aste-Amezaga M., Ma X., Sartori A., Trinchieri G. Molecular mechanisms of the induction of Il-12 and its inhibition by IL-10. J Immunol. 160:(12):1998;5936-5944.
18. Goriely S., Vincart B., Stordeur P., Vekemans J., Willems F., Goldman M., et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol. 166:(3):2001;2141-2146.
19. Langrish C.L., Buddle J.C., Thrasher A.J., Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol. 128:(1):2002;118-123.
20. Pfeffer L.M., Dinarello C.A., Herberman R.B., Williams B.R., Borden E.C., Bordens R., et al. Biological properties of recombinant-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58:1998;2489-2499.
21. Sun S., Zhang X., Tough D.F., Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med. 188:1998;2335-2342.
22. Marrack P., Kappler J., Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 189:1999;521-530.
23. Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol. 14:(4):2002;432-436.
24. Demeure C.E., Wu C.Y., Shu U., Schneider P.V., Heusser C., Yssel H., et al. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol. 152:(10):1994;4775-4782.
25. Cederblad B., Riesenfeld T., Alm G.V. Deficient herpes simplex virus-induced interferon-alpha production by blood leukocytes of preterm and term newborn infants. Pediatr Res. 27:1990;7-10.
26. Neustock P., Kruse A., Bock S., St Pierre B., Kirchner H. Deficient interferon-alpha response of newborns in comparison to adults. Lymphokine Cytokine Res. 12:1993;109-114.